Target intelligence / Profile preview

Gram-positive bacterial cytoplasmic membrane

Molecular classification
Other
01

Overview

The Gram-positive bacterial cytoplasmic membrane is a vital phospholipid bilayer that serves as the primary barrier between the bacterial cytoplasm and the external environment [Strahl & Hamoen, 2010]. It plays a critical role in maintaining cellular homeostasis, facilitating nutrient transport, and hosting essential processes such as oxidative phosphorylation and the synthesis of the peptidoglycan cell wall [Heidary et al., 2022]. In Gram-positive bacteria, this membrane is characterized by a high content of negatively charged phospholipids like phosphatidylglycerol, which makes it a selective target for cationic antimicrobial peptides and lipopeptide antibiotics [Zhanel et al., 2010]. Drugs like daptomycin interact with this membrane in a calcium-dependent manner to cause rapid depolarization and ion leakage, leading to bacterial cell death without requiring entry into the cytoplasm [Heidary et al., 2022]. Because this structure is fundamental to bacterial viability and differs significantly in lipid composition from eukaryotic membranes, it remains a key target for treating multi-drug resistant infections such as methicillin-resistant Staphylococcus aureus (MRSA) [StatPearls, 2023]. However, therapeutic use of membrane-targeting drugs requires monitoring for systemic toxicities, such as elevations in creatine phosphokinase indicative of muscle damage [StatPearls, 2023].

Other names
Bacterial plasma membraneBacterial inner membraneCytoplasmic membrane of Gram-positive bacteria
02

Mechanism of action

Drugs targeting the Gram-positive cytoplasmic membrane typically act by binding to membrane components such as phosphatidylglycerol or Lipid II, leading to membrane depolarization, pore formation, and the leakage of intracellular ions like potassium [Heidary et al., 2022]. This disruption of the membrane potential halts macromolecular synthesis and results in rapid bactericidal activity [Strahl & Hamoen, 2010].

03

Biological functions

Signal transductionOther
04

Disease associations

Infection
05

Safety considerations

MyopathyRhabdomyolysisEosinophilic pneumoniaNephrotoxicity
06

Interacting drugs

Daptomycin

5 more in the full profile.

07

Biomarkers

Creatine phosphokinase (CPK)

Beyond the preview

Go deeper on Gram-positive bacterial cytoplasmic membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-positive bacterial cytoplasmic membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call